Cargando…
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease
Parkinson’s disease is one of the most common neurodegenerative disorders in elderly age. One of the mechanisms involved in the neurodegeneration appears related to the aggregation of the presynaptic protein alpha synuclein (α-syn) into toxic oligomers and fibrils. To date, no highly effective treat...
Autores principales: | Vittorio, Serena, Adornato, Ilenia, Gitto, Rosaria, Peña-Díaz, Samuel, Ventura, Salvador, De Luca, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534360/ https://www.ncbi.nlm.nih.gov/pubmed/32924648 http://dx.doi.org/10.1080/14756366.2020.1816999 |
Ejemplares similares
-
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation
por: De Luca, Laura, et al.
Publicado: (2022) -
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
por: Vittorio, Serena, et al.
Publicado: (2021) -
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
por: Peña-Díaz, Samuel, et al.
Publicado: (2023) -
Small molecules to prevent the neurodegeneration caused by α-synuclein aggregation
por: Peña-Díaz, Samuel, et al.
Publicado: (2020) -
Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)